Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1999
04/01/1999WO1999015671A1 Hepatitis b virus polypeptides
04/01/1999WO1999015566A1 Composition and pharmaceutical preparation containing same for the treatment of herpes and related viral infections
04/01/1999WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
04/01/1999WO1999015548A2 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
04/01/1999WO1999015535A1 Binuclear complex
04/01/1999WO1999015530A1 Tetrazole-containing rapamycin analogs with shortened half-lives
04/01/1999WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
04/01/1999WO1999015522A1 Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent
04/01/1999WO1999015498A1 New npy antagonists
04/01/1999WO1999015205A1 Immunization against streptococcus pneumoniae using conjugated and unconjugated pneumococcal polysaccharide vaccines
04/01/1999WO1999015198A2 Agents for combating bacterial meningitis
04/01/1999WO1999015194A1 Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
04/01/1999WO1999015186A1 Cationic polymers as toxin-binding agents
04/01/1999WO1999015172A1 Medicament formulation with a controlled release of an active agent
04/01/1999WO1999015130A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
04/01/1999WO1999015013A2 Use of quaternary carboxylic acid alkanolamine ester salts as microbicidal agents
04/01/1999WO1999010373B1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection
04/01/1999WO1999002541A3 Erythromycin a oxime solvates
04/01/1999WO1999001117A3 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins
04/01/1999WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
04/01/1999WO1998050554A3 Enterococcus faecalis polynucleotides and polypeptides
04/01/1999DE19742222A1 Verwendung von quaternären Carbonsäurealkanolaminestersalzen als mikrobizide Wirkstoffe Use of quaternary Carbonsäurealkanolaminestersalzen as microbicidal agents
04/01/1999DE19741955A1 Mittel gegen bakterielle Meningitis Medicines for bacterial meningitis
04/01/1999CA2820212A1 Recombinant rsv virus expression systems and vaccines
04/01/1999CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof
04/01/1999CA2304615A1 Agents for combating bacterial meningitis
04/01/1999CA2304244A1 Immunization against streptococcus pneumoniae using conjugated and unconjugated pneumococcal polysaccharide vaccines
04/01/1999CA2304136A1 Composition and pharmaceutical preparation containing same for the treatment of herpes and related viral infections
04/01/1999CA2303528A1 New npy antagonists
04/01/1999CA2303096A1 Binuclear complex
04/01/1999CA2246004A1 A kringle-related clone, hthbz47
03/1999
03/31/1999EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA
03/31/1999EP0905249A2 Alcohol dehydrogenase
03/31/1999EP0905247A2 MurF polynucleotides and polypeptides from Staphylococcus
03/31/1999EP0905246A1 Cloning of chicken anaemia DNA
03/31/1999EP0905245A1 Staphylococcal polypeptides Spo0J1
03/31/1999EP0905244A2 FolC from Streptococcus
03/31/1999EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue
03/31/1999EP0905233A2 Staphylococcus aureus trigger factor
03/31/1999EP0905141A1 Peptide fragment of the limulus anti-LPS factor (LALF) having antiviral action
03/31/1999EP0904694A1 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents
03/31/1999EP0904693A1 Pseudoplastic film-forming acidic chlorite composition as teat dip
03/31/1999EP0904395A1 Herpes simplex virus strains
03/31/1999EP0904394A1 Chicken embryo lethal orphan (celo) virus
03/31/1999EP0904380A2 Synthetic hiv genes
03/31/1999EP0904379A2 Simian-human hav having a chimeric 2c protein
03/31/1999EP0904378A1 Hepatitis b monoclonal antibodies
03/31/1999EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
03/31/1999EP0904351A1 Animal cells and processes for the replication of influenza viruses
03/31/1999EP0904299A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
03/31/1999EP0904291A2 Antipathogenic peptides and compositions comprising them
03/31/1999EP0904289A1 Candida albicans tata-binding protein, nucleic acid and assays
03/31/1999EP0904288A2 Pathogenic escherichia coli associated protein
03/31/1999EP0904285A1 Cyclic adhesion inhibitors
03/31/1999EP0904284A1 6-substituted amino-4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as cysteine protease inhibitors
03/31/1999EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
03/31/1999EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
03/31/1999EP0904106A1 Feline vaccines containing chlamydia psittaci and method for making the same
03/31/1999EP0904105A1 Novel compounds
03/31/1999EP0904104A1 Novel compounds
03/31/1999EP0904098A1 Compositions comprising antifungal agent and acetate buffer
03/31/1999EP0904095A1 Chimeric isoprenoid synthases and uses thereof
03/31/1999EP0904080A1 Inhibitors of farnesyl-protein transferase
03/31/1999EP0904076A1 Inhibitors of farnesyl-protein transferase
03/31/1999EP0904075A1 Method for treating viral infections
03/31/1999EP0904073A1 Zwitterionic compositions and methods as biological response modifiers
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999EP0733035B1 Tricyclic derivatives, pharmaceutical compositions containing them
03/31/1999EP0659752B1 Antibacterial and anti-tumor epoxide derivate dc 114-a1
03/31/1999EP0625158B1 Therapeutic nucleosides of the 2',3'-dideoxy-3'-fluoro-purine series
03/31/1999EP0613480B1 Process for the preparation of cephem derivatives
03/31/1999CN1212723A Disinfecting compositions and process for disinfecting surfaces
03/31/1999CN1212701A Oligonucleotide analogues
03/31/1999CN1212700A Novel erythromycin derivatives, method for preparing same, and use thereof as drug
03/31/1999CN1212685A Azole compounds endowed with antimycotic activity for human and veterinary use
03/31/1999CN1212683A 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
03/31/1999CN1212633A Disinfecting compositions and processes for disinfecting surfaces
03/31/1999CN1212625A Caffeine and clemastine for treating respiratory disorders
03/31/1999CN1212256A Quinolone-and naphthyridone-carboxylic acid derivatives
03/30/1999US5889175 Nucleic acids encoding HIV-1 trans-dominant mutants and their use to abrogate HIV-1 viral replication
03/30/1999US5889171 Genetic engineered polypeptide
03/30/1999US5889168 Fusion glycoprotein from HCMV and HSV
03/30/1999US5889148 Antibiotic peptides
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889038 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
03/30/1999US5889013 Pyrimidine acyclonucleoside derivatives
03/30/1999US5888998 Increase effectiveness of b-lactam antibiotics
03/30/1999US5888977 Therapeutic uses of BPI protein products for human meningococcemia
03/30/1999US5888973 Administering bactericidal/permeability-increasing protein to treat coronary artery disease
03/30/1999US5888941 Carbozamides with antifungal activity
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888770 Spoiiie
03/30/1999US5888517 Protein D-an IgD-binding protein of Haemophilus influenzae
03/30/1999US5888516 Genetic engineered protein
03/30/1999US5888513 Porcine reproductive and respiratory syndrome virus proteins, and amino acid sequences encoding them; produced in a baculovirus expression system using insect cell cultures as host
03/30/1999US5888509 Administering antibody
03/30/1999US5888505 Mixing with halide compound
03/30/1999US5888504 Natural composition for combatting fungi
03/30/1999CA1340473C Method for isolating herpes virus thymidine kinase-encoding dna
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 1798